![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Abdul Majeed, Muhammad Tahir ul Qamar, Arooma Maryam, Muhammad Usman Mirza, Laila Alhussain, Seham Obaid Al Otaibi, Ahmad Almatroudi, Khaled S. Allemailem, Faris Alrumaihi, Abdulaziz A. Aloliqi & Faez Falah Alshehri. (2023) Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now
Read now
Divakar Selvaraj, Santhoshkumar Muthu, Satvik Kotha, Ramachandra Setty Siddamsetty, Sasikumar Andavar & Saravanan Jayaraman. (2021) Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study. Journal of Biomolecular Structure and Dynamics 39:2, pages 621-634.
Read now
Read now
Zhiyong Deng, Paul Cao, Mei Mei Wan & Guangchao Sui. (2010) Yin Yang 1. Transcription 1:2, pages 81-84.
Read now
Read now
Rui Liu, Kui Wang, Kefei Yuan, Yuquan Wei & Canhua Huang. (2010) Integrative oncoproteomics strategies for anticancer drug discovery. Expert Review of Proteomics 7:3, pages 411-429.
Read now
Read now
Mary-Ellen Taplin. (2008) Androgen receptor: role and novel therapeutic prospects in prostate cancer. Expert Review of Anticancer Therapy 8:9, pages 1495-1508.
Read now
Read now
Hongliang Zong, Yayun Chi, Yanlin Wang, Yanzhong Yang, Li Zhang, Haijiao Chen, Jianhai Jiang, Zejuan Li, Yi Hong, Hanzhou Wang, Xiaojing Yun & Jianxin Gu. (2007) Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor. Molecular and Cellular Biology 27:20, pages 7125-7142.
Read now
Read now
Li Jia, Howard C. Shen, Marcus Wantroba, Omar Khalid, Gangning Liang, Qingcai Wang, Elisabet Gentzschein, Jacek K. Pinski, Frank Z. Stanczyk, Peter A. Jones & Gerhard A. Coetzee. (2006) Locus-Wide Chromatin Remodeling and Enhanced Androgen Receptor-Mediated Transcription in Recurrent Prostate Tumor Cells. Molecular and Cellular Biology 26:19, pages 7331-7341.
Read now
Read now
Articles from other publishers (65)
Yongzhen Feng, Shuo Wang, Xingchen Wang, Huiliang Xue, Ming Wu, Lei Chen, Chao Fan, Jinhui Xu & Laixiang Xu. (2023) Photoperiod Regulates the Expression of GPx-5 in the Epididymis of Cricetulus barabensis through Androgen. Biology Bulletin 50:6, pages 1316-1326.
Crossref
Crossref
Md. Mominur Rahman, Galib Muhammad Abrar Ishtiaque, Shahriar Ahmed Rahat, Md. Abid Hossain, Md. Rezaul Islam, Saila Kabir Maeesa, Kajima Rifat, Shopnil Akash, Rabeya Begum, K Hari Chandana, Rohit Sharma, Saima Naz & Abdur Rauf. (2023) Multifunctional Role of Natural Products for Therapeutic Approaches of Prostate Cancer: An Updated Review. Journal of Herbal Medicine 42, pages 100803.
Crossref
Crossref
Dingxie Liu. (2020) AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer. Cellular Oncology 43:2, pages 321-333.
Crossref
Crossref
Luo Li, Zhongbo Du, Yingying Gao, Yu Tang, Yanru Fan, Wei Sun, Ting Li, Nanjing Liu, Mengjuan Yuan, Jiaxin Fan, Lingfang Niu, Jinxiao Yan, Limei Duan, Xiaohou Wu & Chunli Luo. (2019) PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration‐resistant prostate cancer by suppressing the wnt3a/β‐catenin pathway. Journal of Cellular Physiology 234:9, pages 15472-15486.
Crossref
Crossref
Janeen H. Trembley, Betsy T. Kren, Md. J. Abedin, Daniel P. Shaughnessy, Yingming Li, Scott M. Dehm & Khalil Ahmed. (2019) CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression. Pharmaceuticals 12:2, pages 89.
Crossref
Crossref
Zheng Zhang, Bo Jin, Yaqiong Jin, Shengquan Huang, Xiaohua Niu, Zebin Mao & Dianqi Xin. (2017) PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion. Experimental Cell Research 350:1, pages 1-8.
Crossref
Crossref
Smitha Dutt & Allen C. Gao. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
423
445
.
Ravi Pathak, Marc Philizaire & Shiraz Mujtaba. (2015) Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cells. Cancers 7:3, pages 1622-1642.
Crossref
Crossref
Maria Katsogiannou, Hajer Ziouziou, Sara Karaki, Claudia Andrieu, Marie Henry de Villeneuve & Palma Rocchi. (2015) The hallmarks of castration-resistant prostate cancers. Cancer Treatment Reviews 41:7, pages 588-597.
Crossref
Crossref
Benjamin Bonavida & Samantha Kaufhold. (2015) Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target. Pharmacology & Therapeutics 150, pages 149-168.
Crossref
Crossref
Yuan Xu, Hu Zhao & Jianquan Hou. (2014) Correlation between overexpression of EpCAM in prostate tissues and genesis of androgen-dependent prostate cancer. Tumor Biology 35:7, pages 6695-6700.
Crossref
Crossref
Vaishali Kashyap & Benjamin Bonavida. (2014) Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression. Genes & Cancer 5:3-4, pages 71-83.
Crossref
Crossref
Xiangyan Li, Yi-Ting Chen, Peizhen Hu & Wen-Chin Huang. (2014) Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling. Molecular Cancer Therapeutics 13:4, pages 855-866.
Crossref
Crossref
Kaustubh Datta & Donald J. Tindall. 2015. Molecular Oncology. Molecular Oncology
591
597
.
Hu Zhao, Chen Zhu, Chao Qin, Tao Tao, Jie Li, Gong Cheng, Pu Li, Qiang Cao, Xiaoxin Meng, Xiaobing Ju, Pengfei Shao, Lixin Hua, Min Gu & Changjun Yin. (2013) Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP. Biochemical and Biophysical Research Communications 432:2, pages 320-325.
Crossref
Crossref
Kaustubh Datta & Donald J. Tindall. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
35
41
.
Ching‐Yuan Wu, Chang‐Yi Hsieh, Ko‐En Huang, Chawnshang Chang & Hong‐Yo Kang. (2011)
Cryptotanshinone down‐regulates androgen receptor signaling by modulating
lysine‐specific demethylase 1
function
. International Journal of Cancer 131:6, pages 1423-1434.
Crossref
Crossref
Bob Djavan, James Eastham, Leonard Gomella, Bertrand Tombal, Samir Taneja, Seyed Saeid Dianat, Amir Kazzazi, Neal Shore, Per-Anders Abrahamsson, Philippa Cheetham, Judd Moul, Herbert Lepor & E. David Crawford. (2012) Testosterone in prostate cancer: the Bethesda consensus. BJU International 110:3, pages 344-352.
Crossref
Crossref
Linda Kelsey, Parul Katoch, Kristen E. Johnson, Surinder K. Batra & Parmender P. Mehta. (2012) Retinoids Regulate the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells. PLoS ONE 7:4, pages e32846.
Crossref
Crossref
Stephen A. Boorjian & Donald J. Tindall. 2013. Management of Prostate Cancer. Management of Prostate Cancer
117
126
.
Lucas P. Nacusi & Donald J. Tindall. (2011) Targeting 5α-reductase for prostate cancer prevention and treatment. Nature Reviews Urology 8:7, pages 378-384.
Crossref
Crossref
Yingming Li, Majid Alsagabi, Danhua Fan, G. Steven Bova, Ahmed H. Tewfik & Scott M. Dehm. (2011) Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression. Cancer Research 71:6, pages 2108-2117.
Crossref
Crossref
Diping Wang & Donald J. Tindall. 2011. Androgen Action. Androgen Action
25
44
.
Hai-bo SHENG, Bin XU, Jing-jing LIANG & Shan-rong LIU. (2010) Roles of androgen receptor and Wnt signaling pathway in prostate cancer. Academic Journal of Second Military Medical University 30:11, pages 1244-1246.
Crossref
Crossref
Gouhei Tanaka, Yoshito Hirata, S. Larry Goldenberg, Nicholas Bruchovsky & Kazuyuki Aihara. (2010) Mathematical modelling of prostate cancer growth and its application to hormone therapy. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 368:1930, pages 5029-5044.
Crossref
Crossref
Sujit Basu & Donald J. Tindall. (2010) Androgen Action in Prostate Cancer. Hormones and Cancer 1:5, pages 223-228.
Crossref
Crossref
Yiming ZhangShen GaoZhengxin Wang. (2010) Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription. Biochemical Journal 427:3, pages 499-511.
Crossref
Crossref
Joost L. Boormans, Karin G. Hermans, Angelique C.J. Ziel-van der Made, Geert J.H.L. van Leenders, Mark F. Wildhagen, Laurence Collette, Fritz H. Schröder, Jan Trapman & Paul C.M.S. Verhagen. (2010) Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer. European Urology 57:5, pages 830-835.
Crossref
Crossref
X. Edward Zhou, Kelly M. Suino-Powell, Jun Li, Yuanzheng He, Jeffrey P. MacKeigan, Karsten Melcher, Eu-Leong Yong & H. Eric Xu. (2010) Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor. Journal of Biological Chemistry 285:12, pages 9161-9171.
Crossref
Crossref
Bertrand Tombal. (2010) Quand est-ce que je propose un blocage androgénique complet ?. Progrès en Urologie - FMC 20:1, pages F2-F5.
Crossref
Crossref
Smitha S Dutt & Allen C Gao. (2009) Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncology 5:9, pages 1403-1413.
Crossref
Crossref
Z Deng, M Wan, P Cao, A Rao, S D Cramer & G Sui. (2009) Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene 28:42, pages 3746-3757.
Crossref
Crossref
Charles Y.F. Young. 2009. Beer in Health and Disease Prevention. Beer in Health and Disease Prevention
879
888
.
Aiko Miyamura Ideta, Gouhei Tanaka, Takumi Takeuchi & Kazuyuki Aihara. (2008) A Mathematical Model of Intermittent Androgen Suppression for Prostate Cancer. Journal of Nonlinear Science 18:6, pages 593-614.
Crossref
Crossref
Adam T. Szafran, Maria Szwarc, Marco Marcelli & Michael A. Mancini. (2008) Androgen Receptor Functional Analyses by High Throughput Imaging: Determination of Ligand, Cell Cycle, and Mutation-Specific Effects. PLoS ONE 3:11, pages e3605.
Crossref
Crossref
Gouhei Tanaka, Kunichika Tsumoto, Shigeki Tsuji & Kazuyuki Aihara. (2008) Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer. Physica D: Nonlinear Phenomena 237:20, pages 2616-2627.
Crossref
Crossref
Wen-Chin Huang, Jonathan J. Havel, Haiyen E. Zhau, Wei Ping Qian, Hui-Wen Lue, Chia-Yi Chu, Takeo Nomura & Leland W.K. Chung. (2008) β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells. Clinical Cancer Research 14:17, pages 5341-5347.
Crossref
Crossref
Scott M. Dehm, Lucy J. Schmidt, Hannelore V. Heemers, Robert L. Vessella & Donald J. Tindall. (2008)
Splicing of a Novel
Androgen Receptor
Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
. Cancer Research 68:13, pages 5469-5477.
Crossref
Crossref
Håkon Ramberg, Turid Eide, Kurt Allen Krobert, Finn Olav Levy, Nishtman Dizeyi, Anders S Bjartell, Per‐Anders Abrahamsson & Kristin Austlid Taskén. (2008)
Hormonal regulation of β
2
‐adrenergic receptor level in prostate cancer
. The Prostate 68:10, pages 1133-1142.
Crossref
Crossref
Mary-Ellen Taplin, Judith Manola, William K. Oh, Philip W. Kantoff, Glenn J. Bubley, Matthew Smith, Diana Barb, Christos Mantzoros, Edward P. Gelmann & Steven P. Balk. (2008) A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. BJU International 101:9, pages 1084-1089.
Crossref
Crossref
Donald J. Tindall & Roger S. Rittmaster. (2008) The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer. Journal of Urology 179:4, pages 1235-1242.
Crossref
Crossref
A.M. Joshua, A. Evans, T. Van der Kwast, M. Zielenska, A.K. Meeker, A. Chinnaiyan & J.A. Squire. (2008) Prostatic preneoplasia and beyond. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:2, pages 156-181.
Crossref
Crossref
Krisztina Hanley, Jianmin Wang, Patricia Bourne, Qi Yang, Allen C. Gao, Gary Lyman & Ping Tang. (2008) Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Human Pathology 39:3, pages 386-392.
Crossref
Crossref
Scott M. Dehm & Donald J. Tindall. (2007) Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer. Molecular Endocrinology 21:12, pages 2855-2863.
Crossref
Crossref
Hannelore V. Heemers & Donald J. Tindall. (2007) Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex. Endocrine Reviews 28:7, pages 778-808.
Crossref
Crossref
Tasneem Bawa-Khalfe, Jinke Cheng, Zhengxin Wang & Edward T.H. Yeh. (2007) Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells. Journal of Biological Chemistry 282:52, pages 37341-37349.
Crossref
Crossref
Georgios Pampalakis & Georgia Sotiropoulou. (2007) Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1776:1, pages 22-31.
Crossref
Crossref
S. Perner, K.D. Mertz, R. Kuefer & M.A. Rubin. (2007) Biomarker beim ProstatakarzinomBiomarkers for prostate cancer. Der Onkologe 13:8, pages 669-676.
Crossref
Crossref
Hannelore V. Heemers, Thomas J. Sebo, Jose D. Debes, Kevin M. Regan, Kristin A. Raclaw, Linda M. Murphy, Alfred Hobisch, Zoran Culig & Donald J. Tindall. (2007) Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells. Cancer Research 67:7, pages 3422-3430.
Crossref
Crossref
Chih-Cheng Yang, Yu-Chieh Wang, Shuo Wei, Li-Fang Lin, Chang-Shi Chen, Cheng-Chun Lee, Cheng-Chieh Lin & Ching-Shih Chen. (2007) Peroxisome Proliferator-Activated Receptor γ–Independent Suppression of Androgen Receptor Expression by Troglitazone Mechanism and Pharmacologic Exploitation. Cancer Research 67:7, pages 3229-3238.
Crossref
Crossref
Mary-Ellen Taplin. (2007) Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology 4:4, pages 236-244.
Crossref
Crossref
Wei Qi, Hong Wu, Lin Yang, Douglas D Boyd & Zhengxin Wang. (2006) A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. The EMBO Journal 26:1, pages 65-75.
Crossref
Crossref
Joanne N. Davis, Kirk J. Wojno, Stephanie Daignault, Matthias D. Hofer, Rainer Kuefer, Mark A. Rubin & Mark L. Day. (2006) Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer. Cancer Research 66:24, pages 11897-11906.
Crossref
Crossref
Shalini Mitra, Lakshmanan Annamalai, Souvik Chakraborty, Kristen Johnson, Xiao-Hong Song, Surinder K. Batra & Parmender P. Mehta. (2006) Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer Cells. Molecular Biology of the Cell 17:12, pages 5400-5416.
Crossref
Crossref
June X. Zou, Zhenyu Zhong, Xu-Bao Shi, Clifford G. Tepper, Ralph W. deVere White, Hsing-Jien Kung & Hongwu Chen. (2006) ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. The Prostate 66:14, pages 1474-1486.
Crossref
Crossref
Stéphane Terry, Xuezhen Yang, Min‐Wei Chen, Francis Vacherot & Ralph Buttyan. (2006) Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. Journal of Cellular Biochemistry 99:2, pages 402-410.
Crossref
Crossref
Guixia Wang, Kashif A. Ahmad, Gretchen Unger, Joel W. Slaton & Khalil Ahmed. (2006) CK2 signaling in androgen‐dependent and ‐independent prostate cancer. Journal of Cellular Biochemistry 99:2, pages 382-391.
Crossref
Crossref
Jack Schalken. (2006) New Developments in the Pathobiology of Prostate Disease. European Urology Supplements 5:12, pages 729-736.
Crossref
Crossref
Maryla Krajewska, Bruce C. Turner, Ahmed Shabaik, Stan Krajewski & John C. Reed. (2006) Expression of BAG‐1 protein correlates with aggressive behavior of prostate cancers. The Prostate 66:8, pages 801-810.
Crossref
Crossref
Kashif A. Ahmad, Guixia Wang & Khalil Ahmed. (2006) Intracellular Hydrogen Peroxide Production Is an Upstream Event in Apoptosis Induced by Down-Regulation of Casein Kinase 2 in Prostate Cancer Cells. Molecular Cancer Research 4:5, pages 331-338.
Crossref
Crossref
Lauren Wallner, Jinlu Dai, June Escara-Wilke, Jian Zhang, Zhi Yao, Yi Lu, Mohit Trikha, Jeffrey A. Nemeth, Mohamed H. Zaki & Evan T. Keller. (2006) Inhibition of Interleukin-6 with CNTO328, an Anti-Interleukin-6 Monoclonal Antibody, Inhibits Conversion of Androgen-Dependent Prostate Cancer to an Androgen-Independent Phenotype in Orchiectomized Mice. Cancer Research 66:6, pages 3087-3095.
Crossref
Crossref
N Chen, M N Szentirmay, S A Pawar, M Sirito, J Wang, Z Wang, Q Zhai, H-X Yang, D M Peehl, J L Ware & M Sawadogo. (2005) Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis. Oncogene 25:4, pages 579-587.
Crossref
Crossref
Kashif A. Ahmad, Guixia Wang, Joel Slaton, Gretchen Unger & Khalil Ahmed. (2005) Targeting CK2 for cancer therapy. Anti-Cancer Drugs 16:10, pages 1037-1043.
Crossref
Crossref
Guangchun Chen, Masatoshi Nomura, Hidetaka Morinaga, Eri Matsubara, Taijiro Okabe, Kiminobu Goto, Toshihiko Yanase, Hong Zheng, Jian Lu & Hajime Nawata. (2005) Modulation of Androgen Receptor Transactivation by FoxH1. Journal of Biological Chemistry 280:43, pages 36355-36363.
Crossref
Crossref
Tanya Stoyanova, Busola Ruth Alabi & Shiqin Liu. (2022) Current and Emerging Therapies for Neuroendocrine Prostate Cancer. SSRN Electronic Journal.
Crossref
Crossref